Pathway Financial Advisers’s Lam Research LRCX Stock Holding History

Pathway Financial Advisers’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.67M	Sell	10,785 -22	-0.2%	-$6.68K	1.18%	29
2026 Q1	$2.31M	Sell	10,807 -561	-5%	-$125K	0.65%	57
2025 Q4	$1.95M	Sell	11,368 -24	-0.2%	-$3.73K	0.56%	65
2025 Q3	$1.52M	Sell	11,392 -1	-0%	-$106	0.44%	74
2025 Q2	$1.11M	Buy	11,393 +96	+0.8%	+$7.61K	0.36%	89
2025 Q1	$821K	Buy	11,297 +1,606	+17%	+$126K	0.28%	100
2024 Q4	$700K	Buy	9,691 +671	+7%	+$50.9K	0.23%	109
2024 Q3	$736K	Buy	9,020 +330	+4%	+$28.7K	0.33%	77
2024 Q2	$905K	Sell	8,690 -100	-1%	-$9.59K	0.32%	94
2024 Q1	$854K	Sell	8,790 -430	-5%	-$37.8K	0.31%	97
2023 Q4	$722K	Sell	9,220 -40	-0.4%	-$2.73K	0.27%	101
2023 Q3	$582K	Buy	+9,260	New	+$608K	0.24%	107
2023 Q1	$521K	Buy	9,830 +2,870	+41%	+$141K	0.21%	112
2022 Q4	$292K	Buy	+6,960	New	+$291K	0.12%	140

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pathway Financial Advisers's LRCX Position: Q2 2026 in Review

Pathway Financial Advisers reduced its Lam Research (LRCX) stake by 0.2% in Q2 2026, selling an estimated $6.68K and leaving 10,785 shares worth $4.67M. The position accounts for 1.18% of the portfolio, ranked #29.

Pathway Financial Advisers first reported a position in LRCX in Q4 2022 and has held it in 14 quarters since. 3,121 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Pathway Financial Advisers held 10,785 shares of Lam Research worth $4.67M as of Q2 2026.
Pathway Financial Advisers sold 22 Lam Research shares in Q2 2026, an estimated $6.68K.
Lam Research made up 1.18% of Pathway Financial Advisers's portfolio in Q2 2026, its #29 holding.
Pathway Financial Advisers first reported a position in Lam Research in Q4 2022 and has held it in 14 quarters since.
3,121 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.